Sichuan Biokin Pharmaceutical Co Ltd (688506) Stock Price & News

688506:SHA

Sichuan Biokin Pharmaceutical Co Ltd

CN¥260.31

+1.23%

(+3.16) 1D

Nov 4, 3:00:02 PM GMT+8 · CNY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 688506...

Open

CN¥255.66

High

CN¥263.54

Low

CN¥252.50

Mkt. cap

106.17B

Avg. vol.

1.69M

Volume

1.97M

52-wk high

CN¥404.00

52-wk low

CN¥200.10

EPS

-CN¥3.08

No. of employees

Open

CN¥255.66

High

CN¥263.54

Low

CN¥252.50

Mkt. cap

106.17B

Avg. vol.

1.69M

Volume

1.97M

52-wk high

CN¥404.00

52-wk low

CN¥200.10

EPS

-CN¥3.08

No. of employees

Related stocks

600276

Jiangsu Hengrui Pharmaceuticals Co Ltd

CN¥49.05

-0.53%

600196

Shanghai Fosun Pharmaceutical (Group) Ord Shs A

CN¥23.27

+1.13%

688578

Shanghai Allist Pharmaceuticals Co Ltd

CN¥85.99

+3.50%

002422

Sichuan Kelun Pharmaceutical Co Ltd

CN¥43.48

+7.97%

News stories

From web sources and news partners

Quantisnow

5 minutes ago

/C O R R E C T I O N - SVRN, Inc./

Virginia Business

1 hour ago

Accendra Health could be delisted by NYSE

hngnews.com

26 minutes ago

Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections

CNN

8 hours ago

CVS to split into two companies, in major breakup of its $117 billion healthcare empire

Profile

Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia

About Sichuan Biokin Pharmaceutical Co Ltd

CEO-

Employees3.43K

FoundedAug 23, 1996

Headquarters-

SectorPharmaceutical industry

Industry-

Websiteen.baili-pharm.com

All values in CNY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	454.22M	94.59M	92.75M	1.91B
Cost of goods sold	115.66M	43.37M	59.34M	54.87M
Cost of revenue	115.66M	43.37M	59.34M	54.87M
Research and development expenses	741.34M	694.76M	787.93M	562.80M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	169.94M	126.35M	113.01M	172.21M
Operating expense	926.05M	813.01M	892.42M	731.02M
Total operating expenses	1.04B	856.38M	951.76M	785.89M
Operating income	-587.49M	-761.79M	-859.01M	1.12B
Other non operating income	68.05M	-142.74M	142.75M	-280.89M
EBT including unusual items	-535.84M	-776.15M	-901.42M	1.09B
EBT excluding unusual items	-586.93M	-841.61M	-965.12M	1.10B
Income tax expense	23.26M	-1.59M	-38.76M	161.48M
Effective tax rate	-4.34%	0.21%	4.30%	14.76%
Other operating expenses	14.55M	-7.43M	-9.01M	-4.55M
Net income	-559.10M	-774.56M	-862.66M	932.30M
Net profit margin	-123.09%	-818.89%	-930.11%	48.90%
Earnings per share	-	-	-	-
Interest and investment income	56.43M	89.48M	36.67M	37.90M
Interest expense	-26.18M	-26.56M	-29.06M	-36.96M
Net interest expenses	30.26M	62.92M	7.62M	934.36K
Depreciation and amortization charges	-	-	-	-
EBITDA	-567.21M	-741.51M	-836.43M	1.14B
Gain or loss from assets sale	-1.06K	-	-	-

Finance

Ask anything